Company Overview - Aladdin Biochemical Technology Co., Ltd. is located at 36 Nanta, Xinjinqiao Road, Pudong New District, Shanghai, established on March 16, 2009, and listed on October 26, 2020. The company specializes in the research, production, and sales of reagents, with main business revenue composition: 96.96% from research reagents, 2.15% from laboratory consumables, and 0.89% from other sources [1]. Stock Performance - As of September 3, Aladdin's stock price decreased by 0.92%, trading at 12.91 CNY per share, with a total transaction volume of 86.79 million CNY and a turnover rate of 2.00%. The total market capitalization stands at 4.294 billion CNY. The stock has experienced a continuous decline for 8 days, with a cumulative drop of 18.6% during this period [1]. Fund Holdings - Morgan Stanley's fund has a significant position in Aladdin, with the "Morgan Stanley Youyue Anhe Mixed A" fund (009893) increasing its holdings by 59,700 shares in the second quarter, totaling 275,900 shares, which accounts for 5.24% of the fund's net value, ranking it as the sixth-largest holding. The estimated floating loss today is approximately 33,100 CNY, with a total floating loss of 813,800 CNY during the 8-day decline [2]. Fund Performance - The "Morgan Stanley Youyue Anhe Mixed A" fund was established on September 24, 2020, with a current size of 28.9066 million CNY. Year-to-date returns are 20.64%, ranking 3666 out of 8180 in its category, while the one-year return is 31.74%, ranking 4447 out of 7967. Since inception, the fund has incurred a loss of 28.99% [2]. Fund Manager Information - The fund manager of "Morgan Stanley Youyue Anhe Mixed A" is Zhao Weijie, who has been in the position for 4 years and 185 days. The total asset size under management is 305 million CNY, with the best fund return during his tenure being 23.35% and the worst being -31% [2].
阿拉丁股价连续8天下跌累计跌幅18.6%,摩根士丹利基金旗下1只基金持27.59万股,浮亏损失81.38万元